A postpartum patient is exhibiting signs of significant blood loss, uterine atony, and potential coagulopathy. After initial assessment and stabilization measures, what is the most important nursing intervention to prioritize in order to prevent further complications?

C) Prepare the patient for immediate surgical intervention.

A) Initiate large-bore IV access and administer isotonic fluids.

B) Monitor vital signs every 15 minutes and assess for changes.

C) Prepare the patient for immediate surgical intervention.

D) Administer prescribed uterotonic agents and reassess uterine tone.

A postpartum patient is showing signs of significant blood loss and potential disseminated intravascular coagulation (DIC) due to retained placental fragments. What is the nurse's immediate priority intervention while the team prepares for an urgent surgical procedure?

B) Begin aggressive fluid resuscitation to stabilize hemodynamic status.

A) Initiate a rapid blood transfusion to address the low hemoglobin and hematocrit levels.

B) Begin aggressive fluid resuscitation to stabilize hemodynamic status.

C) Administer uterotonic agents to promote uterine contraction and address uterine atony.

D) Monitor coagulation studies closely to anticipate further development of coagulopathy.

A patient is experiencing persistent hypovolemic shock and impaired oxygenation post-surgery for retained placental tissue. Despite intervention, her condition remains unstable, with signs of Disseminated Intravascular Coagulation (DIC) and acute kidney injury. What is the most critical nursing intervention to prioritize in managing this patient's care?

C) Administer fresh frozen plasma and cryoprecipitate to correct coagulopathy.

A) Increase supplemental oxygen to maintain saturation levels.

B) Initiate renal replacement therapy to address acute kidney injury.

C) Administer fresh frozen plasma and cryoprecipitate to correct coagulopathy.

D) Administer diuretics to manage fluid overload and support renal function.

A patient undergoing treatment for retained placental tissue is experiencing hypovolemic shock and DIC, despite the use of blood transfusions and uterotonic agents. Given the current clinical picture, which nursing intervention should be prioritized to address the patient's critical condition?

C) Administer fresh frozen plasma and cryoprecipitate to manage coagulopathy.

A) Increase the rate of intravenous crystalloids to improve blood pressure.

B) Prepare the patient for renal replacement therapy to address acute kidney injury.

C) Administer fresh frozen plasma and cryoprecipitate to manage coagulopathy.

D) Increase oxygen supplementation to 10L via a non-rebreather mask to improve saturation.

A patient with deteriorating renal function and altered mental status is being prepared for continuous venovenous hemofiltration (CVVH). Given her current hemodynamic instability and worsening metabolic acidosis, what should the critical care nurse prioritize to prevent further multi-organ failure?

B) Initiate norepinephrine infusion to stabilize hemodynamics before starting CVVH.

A) Administer a fluid bolus to improve blood pressure and tissue perfusion.

B) Initiate norepinephrine infusion to stabilize hemodynamics before starting CVVH.

C) Prepare for invasive mechanical ventilation to improve oxygenation and reduce metabolic demands.

D) Increase supplemental oxygen to 15L via non-rebreather mask to improve oxygen saturation.

A critical care nurse is managing a patient with deteriorating renal function, altered mental status, and worsening metabolic acidosis. The interdisciplinary team has initiated continuous venovenous hemofiltration (CVVH) and is considering further interventions. Which of the following actions should the nurse prioritize to address the patient's current hemodynamic instability and ensure tissue oxygenation?

B) Initiate vasopressor therapy to stabilize blood pressure and improve perfusion.

A) Increase the rate of fluid resuscitation to rapidly improve blood pressure.

B) Initiate vasopressor therapy to stabilize blood pressure and improve perfusion.

C) Escalate to invasive mechanical ventilation to support respiratory function.

D) Administer sodium bicarbonate to correct the metabolic acidosis.

A patient undergoing continuous venovenous hemofiltration (CVVH) presents with a further drop in hemoglobin, prolonged prothrombin time, elevated D-dimer, and a low platelet count. Despite fluid resuscitation and vasopressor support, the patient remains hemodynamically unstable with elevated heart rate and fluctuating blood pressure. New-onset chest pain and ST segment depression raise the suspicion of myocardial ischemia. What is the priority nursing intervention to address the current hemodynamic instability and potential cardiac compromise?

B) Administer a platelet transfusion to address the thrombocytopenia and potential bleeding risks.

A) Increase the norepinephrine infusion rate to maintain MAP above 65 mmHg.

B) Administer a platelet transfusion to address the thrombocytopenia and potential bleeding risks.

C) Initiate invasive mechanical ventilation to improve oxygenation and correct metabolic acidosis.

D) Administer a dose of nitroglycerin to relieve chest pain and reduce cardiac workload.

A patient with myocardial ischemia, ongoing DIC, and hemodynamic instability is being managed with low-dose aspirin, NIPPV, and norepinephrine. Considering her current condition, which of the following nursing interventions is most critical in optimizing her care plan?

C) Regularly assess lung sounds and respiratory status for signs of fluid overload.

A) Initiate a fluid bolus to improve renal perfusion.

B) Increase the dose of norepinephrine to maintain systolic blood pressure above 120 mmHg.

C) Regularly assess lung sounds and respiratory status for signs of fluid overload.

D) Encourage the patient to engage in early mobilization to enhance circulation.

A critically ill patient with ongoing DIC and suspected myocardial ischemia has been initiated on low-dose aspirin therapy. The echocardiogram shows moderate left ventricular dysfunction, and the patient is on NIPPV to improve oxygenation. Given the persistent hypotension requiring high-dose norepinephrine and scant urine output, what is the most appropriate nursing intervention to prioritize in this clinical situation?

D) Collaborate with the healthcare team to reassess fluid balance and adjust therapy accordingly.

A) Increase the infusion rate of norepinephrine to maintain adequate blood pressure.

B) Initiate a rapid bolus of intravenous fluids to improve renal perfusion.

C) Adjust the NIPPV settings to enhance oxygen delivery and reduce cardiac workload.

D) Collaborate with the healthcare team to reassess fluid balance and adjust therapy accordingly.

postpartum hemorrhage - Nursing Case Study

Pathophysiology

• Primary mechanism: Uterine atony, the failure of the uterus to contract adequately after delivery, leads to insufficient compression of the blood vessels at the placental site, resulting in excessive bleeding. This is the most common cause of postpartum hemorrhage and is often associated with factors like prolonged labor, overdistended uterus, or use of certain medications.

• Secondary mechanism: Retained placental tissue prevents proper uterine contraction and can cause continued blood vessel hemorrhage. This occurs when fragments of the placenta or membranes remain in the uterus, disrupting normal hemostasis and prolonging bleeding.

• Key complication: Both mechanisms can lead to hypovolemic shock, a severe systemic response characterized by decreased blood volume, reduced cardiac output, and inadequate tissue perfusion, posing a critical risk to maternal health.

Patient Profile

Demographics:

32-year-old female, registered nurse

History:

• Key past medical history: Gestational diabetes, hypertension, previous cesarean section

• Current medications: Labetalol, insulin, prenatal vitamins

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Severe vaginal bleeding after childbirth

• Key symptoms: Dizziness, shortness of breath, palpitations, decreased urine output

• Vital signs: Blood pressure 85/50 mmHg, heart rate 130 bpm, respiratory rate 28 breaths per minute, temperature 36.5°C, oxygen saturation 88% on room air

Section 1

Initial Assessment Findings:

Upon arrival at the postpartum unit, a rapid assessment reveals that the patient is pale and diaphoretic, exhibiting signs of significant blood loss. Her skin is cool and clammy to the touch, and she appears lethargic, responding only minimally to verbal stimuli. Auscultation of the lungs reveals diminished breath sounds bilaterally, and peripheral pulses are weak and thready, indicating compromised circulation. The patient's abdomen is distended and tender, with a fundal height that is higher than expected for the postpartum period, suggesting uterine atony. Despite attempts at uterine massage, the uterus remains boggy and unresponsive to initial interventions.

A stat hemoglobin and hematocrit are drawn, revealing hemoglobin levels at 7 g/dL and hematocrit at 21%, confirming significant blood loss. Coagulation studies show a prolonged prothrombin time (PT) and activated partial thromboplastin time (aPTT), indicating potential coagulopathy. These findings suggest that the patient may be developing disseminated intravascular coagulation (DIC), a serious complication often associated with obstetric hemorrhage. Additionally, a bedside ultrasound is performed, which identifies retained placental fragments within the uterine cavity, further contributing to the ongoing bleeding and uterine atony.

The combination of vital signs, lab findings, and ultrasound results necessitates immediate interdisciplinary intervention. The obstetric team prepares for an urgent surgical procedure to evacuate retained placental tissue, while the intensive care team stabilizes the patient with aggressive fluid resuscitation, blood transfusions, and administration of uterotonic agents. Continuous monitoring and reevaluation of hemodynamic status are critical as the team navigates these multifaceted challenges, emphasizing the importance of advanced clinical judgment and prompt decision-making to prevent further deterioration.

Section 2

As the surgical team proceeds with the evacuation of retained placental tissue, the patient's condition remains precarious, necessitating close monitoring and swift reassessment. Despite the initiation of blood transfusions and uterotonic agents, the patient's vital signs continue to reflect instability. Her blood pressure drops to 80/50 mmHg, and heart rate accelerates to 130 bpm, indicating persistent hypovolemic shock. Her oxygen saturation fluctuates between 88-92% on 5L of supplemental oxygen via nasal cannula, suggesting impaired oxygenation possibly exacerbated by the diminished breath sounds noted earlier.

The interdisciplinary team convenes to address the new diagnostic results: a complete blood count reveals further decline in hemoglobin to 6.5 g/dL, and platelet count drops to 90,000/mcL, reinforcing the likelihood of DIC. Fibrinogen levels are critically low, and D-dimer levels are markedly elevated, confirming the activation of systemic coagulation pathways. The patient's renal function is also compromised, with serum creatinine rising to 2.1 mg/dL, indicating acute kidney injury potentially due to hypoperfusion. These findings necessitate a multifaceted approach, including the administration of fresh frozen plasma and cryoprecipitate to address coagulopathy, along with continued aggressive fluid and blood product resuscitation.

As the surgical team successfully removes the retained placental fragments, the patient exhibits a transient improvement in uterine tone, yet the challenge remains to stabilize her overall hemodynamic status. The critical care team must now balance fluid resuscitation with the risk of fluid overload, given her compromised cardiac and renal function. The emergence of oliguria, with a urine output of less than 20 mL/hour, prompts consideration of renal support therapies. The team must employ advanced clinical reasoning to prioritize interventions, anticipate potential complications, and adjust the evolving treatment plan to optimize patient outcomes and prevent irreversible organ damage.

Section 3

As the team continues to manage this complex case, the patient's status takes a concerning turn. Despite ongoing transfusions and coagulation support, her condition deteriorates further, evidenced by a significant drop in urine output to 10 mL/hour, exacerbating concerns about acute kidney injury. Her mental status alters, with the patient becoming increasingly lethargic and difficult to rouse, a potential sign of cerebral hypoperfusion or the progression of DIC affecting the central nervous system. Neurological assessment reveals sluggish pupillary reactions and a Glasgow Coma Scale score of 10, necessitating immediate intervention to prevent further cerebral compromise.

In response to the declining renal function and altered mental status, the interdisciplinary team decides to initiate renal replacement therapy. This decision is complex, balancing the need to manage fluid overload against the risk of further hemodynamic instability. As preparations for continuous venovenous hemofiltration (CVVH) begin, the patient’s vital signs remain tenuous; blood pressure fluctuates between 75/45 mmHg and 85/50 mmHg, with heart rate persistently elevated at 135 bpm. The patient’s oxygen saturation has further declined, now consistently around 86% despite increasing supplemental oxygen to 10L via mask. Arterial blood gas analysis reveals a worsening metabolic acidosis, with a pH of 7.25 and bicarbonate level of 14 mEq/L, underscoring the severity of her condition.

The team must now evaluate the effectiveness of current interventions, considering additional strategies such as advanced hemodynamic monitoring and possibly escalating to invasive ventilation support to ensure adequate tissue oxygenation. The critical care nurse, coordinating with the intensive care physician, must prioritize interventions that address both the immediate life-threatening issues and the underlying pathophysiological processes. This requires anticipating possible complications, such as further cardiovascular compromise or the need for more aggressive respiratory support, while maintaining a vigilant watch for any signs of improvement or deterioration. Each decision is crucial in this high-stakes scenario, with the ultimate goal of stabilizing the patient and preventing multi-organ failure.

Section 4

As the team implements continuous venovenous hemofiltration (CVVH), the patient’s condition continues to evolve, presenting new challenges. Approximately one hour into the CVVH initiation, a repeat set of laboratory results reveals a further drop in hemoglobin to 6.5 g/dL, indicating ongoing blood loss or inadequate response to transfusion efforts. Additionally, coagulation studies show a prolonged prothrombin time (PT) of 22 seconds and an elevated D-dimer, consistent with the worsening of disseminated intravascular coagulation (DIC). The patient's platelet count has plummeted to 30,000/µL, necessitating an urgent review of the anticoagulation strategy used during CVVH and consideration of additional blood product support, such as platelet transfusions.

Clinically, the patient's hemodynamic status remains precarious. Despite aggressive fluid resuscitation and vasopressor support with norepinephrine titrated to maintain mean arterial pressure (MAP) above 65 mmHg, her blood pressure continues to fluctuate, and the heart rate remains elevated, now at 140 bpm. Intriguingly, her oxygen saturation begins to improve slightly to 90% after transitioning to high-flow nasal cannula oxygen therapy, suggesting a partial amelioration in respiratory function. However, the metabolic acidosis persists, with a repeat arterial blood gas showing a pH of 7.28 and bicarbonate level of 16 mEq/L. The team faces a critical decision: whether to escalate to invasive ventilation to better manage her respiratory status and potentially improve metabolic acidosis through controlled ventilation.

Amid these developments, a concerning new complication arises: signs of potential cardiac involvement. The patient begins to exhibit new-onset chest pain, and an electrocardiogram reveals ST segment depression in the lateral leads, raising suspicion for myocardial ischemia. Troponin levels are pending, but the clinical picture suggests cardiac strain, likely secondary to the severe and sustained hemodynamic instability. The interdisciplinary team must now prioritize interventions to address this potential cardiac complication while continuing to manage the broader picture of multi-organ dysfunction, requiring a re-evaluation of current therapies and perhaps the initiation of additional cardiac protective measures. The scenario demands seamless coordination and expert clinical reasoning to navigate the complexities of this rapidly changing and life-threatening situation.

Section 5

The clinical team gathers to re-evaluate the situation in light of the patient's new-onset chest pain and suspected myocardial ischemia. A stat troponin test returns elevated, confirming myocardial injury. Considering the patient's fragile state, characterized by ongoing DIC and hemodynamic instability, the team must carefully balance the risks and benefits of initiating anticoagulant therapy, typically indicated in ischemic events, against the potential for exacerbating bleeding. The decision is made to administer low-dose aspirin as a compromise, seeking to mitigate further cardiac events without significantly increasing hemorrhagic risk.

Simultaneously, an echocardiogram is performed at the bedside, revealing moderate left ventricular dysfunction with an ejection fraction of 40%, further reinforcing the likelihood of cardiac strain secondary to prolonged hypotension and hypoxia. The team transitions the patient to non-invasive positive pressure ventilation (NIPPV) in an attempt to improve oxygenation and reduce cardiac workload. This choice reflects a nuanced approach, aiming to optimize respiratory support while avoiding the potential complications of invasive mechanical ventilation.

Despite these efforts, the patient remains critically ill. Her blood pressure continues to require high doses of norepinephrine, and urine output is scant, indicating persistent renal impairment. A comprehensive re-evaluation of her fluid status is undertaken, with ultrasonography guiding fluid management to avoid exacerbating pulmonary edema or compromising cardiac function. The next steps involve a delicate balance of titrating vasopressors, adjusting fluid therapy, and closely monitoring cardiac status, all while preparing for potential escalation to more aggressive measures if her condition does not stabilize. The challenge lies in integrating these complex interventions seamlessly to support the patient through this precarious phase.